CompanyGraph
Shandong Weigao Group Medical Polymer Co. Ltd.
1066 · HKEX · China
Price data from its UK2 listing on XSTU, quoted in EUR
weigaogroup.comFinancials as of FY2025
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $3.17B, above the global median of $1.15B
- PositionP/E ratio is 8.55×, lower than 95% of its Medical Instruments & Supplies peers (median 41.06×)
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
3.97%Above 5Y avg (3.10%)
Annual Rate
HKD 0.14Paid semi-annual
Payout Ratio
63.0%Moderate
Payback Period
2.1 yr
Last Ex-Dividend
Jun 2, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
24.87BHKD3.17B · vs all stocks (USD)
Trailing P/E
8.55xvs Medical Instruments & Supplies peers
Revenue (TTM)
15.58BCNY1.99B · vs all stocks (USD)
Profit Margin
12.04%vs Medical Instruments & Supplies peers
Beta
0.3660xvs all stocks
52-Week Change
-48.37%vs all stocks
Forward Annual Dividend Yield
3.97%vs all stocks
Market Capitalization
24.87BHKD3.17B · vs all stocks (USD)
Enterprise Value
15.05BHKD1.92B · vs all stocks (USD)
Trailing P/E
8.55xvs Medical Instruments & Supplies peers
Forward P/E
6.43xvs Medical Instruments & Supplies peers
PEG Ratio
0.3206xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
1.16xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
0.5671xvs Medical Instruments & Supplies peers
Enterprise to Revenue
0.9660xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
4.70xvs Medical Instruments & Supplies peers
Gross Margin
59.04%vs Medical Instruments & Supplies peers
Profit Margin
12.04%vs Medical Instruments & Supplies peers
Operating Margin
9.94%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
3.26%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
6.69%vs Medical Instruments & Supplies peers
Revenue (TTM)
15.58BCNY1.99B · vs all stocks (USD)
Revenue per Share (TTM)
2.95CNYUpdated Aug 19, 2026Quarterly Revenue Growth
4.50%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
7.36BCNY938.78M · vs all stocks (USD)
EBITDA (TTM)
1.14BCNY145.06M · vs all stocks (USD)
Net Income (TTM)
1.88BCNY239.20M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-37.00%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
2.97BCNY378.43M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
1.48BCNY188.21M · vs all stocks (USD)
Forward Annual Dividend Rate
0.1376HKDUpdated Aug 19, 2026Forward Annual Dividend Yield
3.97%vs all stocks
Trailing Annual Dividend Rate
0.1749HKDUpdated Aug 19, 2026Trailing Annual Dividend Yield
5.05%vs all stocks
5-Year Average Dividend Yield
3.10%vs all stocks
Payout Ratio
63.03%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
1.71BCNYFY2025 · Dec 31, 2025Revenue
13.39BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
7.02BCNYFY2025 · Dec 31, 2025Gross Profit
6.37BCNYFY2025 · Dec 31, 2025Operating Income
1.93BCNY286.90M · vs all stocks (USD)
Pre-tax Income
2.03BCNYFY2025 · Dec 31, 2025Income Tax Expense
320.79MCNYFY2025 · Dec 31, 2025Net Income
1.71BCNYFY2025 · Dec 31, 2025EBIT
2.29BCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
3.16BCNYFY2025 · Dec 31, 2025Research & Development
646.59MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
3.80BCNYFY2025 · Dec 31, 2025Other Operating Expenses
34.54MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
188.43MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
255.85MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.3600CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.3500CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
4.54BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
4.54BSharesFY2025 · Dec 31, 2025Minority Interests (P&L)
-98.49MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
1.94BCNYFY2025 · Dec 31, 2025Free Cash Flow
1.32BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
6.31BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
2.03BCNYFY2025 · Dec 31, 2025Stock-based Compensation
73.97MCNYFY2025 · Dec 31, 2025Other Non-cash Items
128.19MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-74.45MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-223.26MCNYFY2025 · Dec 31, 2025Capital Expenditures
-616.35MCNYFY2025 · Dec 31, 2025Net Intangibles (CF)
-47.92MCNYFY2025 · Dec 31, 2025Net Acquisitions
-45.40MCNYFY2025 · Dec 31, 2025Purchase of Investments
-6.78BCNYFY2025 · Dec 31, 2025Sale of Investments
7.01BCNYFY2025 · Dec 31, 2025Other Investing Activity
-18.53MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-448.30MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
2.27BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.46BCNYFY2025 · Dec 31, 2025Common Stock Repurchase
-159.48MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-1.03BCNYFY2025 · Dec 31, 2025Other Financing Charges
-103.00MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-456.69MCNYFY2025 · Dec 31, 2025Shares Outstanding
4.48BSharesUpdated Aug 19, 2026Float Shares
2.35BSharesUpdated Aug 19, 2026% Held by Insiders
47.67%vs all stocks
% Held by Institutions
23.88%vs all stocks
Total Cash (MRQ)
11.00BCNY1.40B · vs all stocks (USD)
Total Cash per Share (MRQ)
2.08CNYUpdated Aug 19, 2026Total Debt (MRQ)
5.94BCNY757.20M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.1977xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
3.78xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
6.18CNYUpdated Aug 19, 2026Total Assets
36.05BCNY5.35B · vs all stocks (USD)
Total Current Assets
20.66BCNYFY2025 · Dec 31, 2025Total Liabilities
10.23BCNYFY2025 · Dec 31, 2025Total Non-current Assets
15.39BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
4.76BCNYFY2025 · Dec 31, 2025Total Current Liabilities
5.47BCNYFY2025 · Dec 31, 2025Cash
8.57BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
8.57BCNYFY2025 · Dec 31, 2025Other Short-term Investments
883.05MCNYFY2025 · Dec 31, 2025Accounts Receivable
7.83BCNYFY2025 · Dec 31, 2025Inventory
2.52BCNYFY2025 · Dec 31, 2025Accounts Payable
2.07BCNYFY2025 · Dec 31, 2025Short-term Debt
498.43MCNYFY2025 · Dec 31, 2025Long-term Debt
4.61BCNYFY2025 · Dec 31, 2025Common Stock (Book)
457.06MCNYFY2025 · Dec 31, 2025Retained Earnings
20.47BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
25.82BCNY3.83B · vs all stocks (USD)
Treasury Stock
159.48MCNYFY2025 · Dec 31, 202552-Week Low
2.92HKDUpdated Aug 19, 202652-Week High
6.98HKDUpdated Aug 19, 202652-Week Change
-48.37%vs all stocks
Beta
0.3660xvs all stocks
50-Day MA
3.32HKDUpdated Aug 19, 2026200-Day MA
4.34HKDUpdated Aug 19, 2026Avg 10-Day Volume
15.86MSharesUpdated Aug 19, 2026Avg 30-Day Volume
15.92MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.4100CNYUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 8.55×, lower than 95% of its Medical Instruments & Supplies peers (median 41.06×)Notable
P/E ratio: 8.55Industry median: 41.06Industry P5: 15.01Peers compared: 35.00
Price-to-book is 0.57×, lower than 95% of its Medical Instruments & Supplies peers (median 3.66×)Notable
Price-to-book: 0.57Industry median: 3.66Industry P5: 1.01Peers compared: 35.00
Financial Health
Altman Z-Score 3.13: safe zoneNotable
Altman Z-Score: 3.13
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $3.17B, above the global median of $1.15BNotable
Market cap (USD): 3,170,859,732.994Global Median: 1,146,734,693.424
Revenue is $1.99B, above the global median of $520.53MNotable
Revenue (USD): 1,986,513,805.86Global Median: 520,528,949.311
Levered free cash flow is $188.21M, above the global median of $16.24MNotable
Levered free cash flow (USD): 188,213,984.338Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Zhuzhou Hongda Electronics Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Huada Automotive Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Vicat S.A.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Ningbo Sanxing Medical Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Veeco Instruments Inc.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Xiamen Hengkun New Materials Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
China Wafer Level CSP Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Cheng Shin Rubber Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Tianneng Battery Group Co Ltd
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guangdong Create Century Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule